imaging agent (NuView/University of New Mexico)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameimaging agent (NuView/University of New Mexico)
Drug Alias Name213Bi-DOTATOC213Bi-[DOTA0, Tyr3] Octreotide
ClassificationRadiation-emitting products
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNuview Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A